Trial Profile
An Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral Molidustat in Peritoneal Dialysis Subjects With Renal Anemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2021
Price :
$35
*
At a glance
- Drugs Molidustat (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms MIYABI PD
- Sponsors Bayer; Bayer Yakuhin
- 09 Dec 2021 New source identified and integrated (Japan Pharmaceutical Information Center - Clinical Trials Information record: JapicCTI183854).
- 14 Aug 2019 Status changed from active, no longer recruiting to completed.
- 18 Nov 2018 Planned End Date changed from 9 Nov 2019 to 31 Aug 2019.